Clinical trial
Randomized, Single-blind, Cross-over Study Investigating the Non-inferiority of Efficacy and Safety of HyQvia in Comparison With Conventional Subcutaneous Ig Therapy in Multifocal Motor Neuropathy
NCT02556437 is registered in ClinicalTrials.gov with Johannes Jakobsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Single-blind, Cross-over Study Investigating the Non-inferiority of Efficacy and Safety of HyQvia in Comparison With Conventional Subcutaneous Ig Therapy in Multifocal Motor Neuropathy
- Lead sponsor
- Johannes Jakobsen
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- May 31, 2018
- Enrollment
- 18 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
multifocal motor neuropathy